Bilik Wicara

Early detection of tuberculosis (TB) and COPD remains a major challenge. Conventional methods often require time, expensive equipment, and invasive procedures, leading to potentially fatal delays in treatment. The world needs screening methods that are faster, more accessible, and less intimidating for patients.

Bilik Wicara addresses this need with a revolutionary acoustic biomarker. We are delivering a cutting-edge screening solution that utilizes Artificial Intelligence to analyze the characteristics of breath sounds to detect abnormalities invisible to the human ear. This is a major leap forward in the effort to create a TB-free world.

Key Benefits:

For Medical Personnel and Healthcare Facilities:
1. Rapidly identify high-risk patients and prioritize them for advanced diagnostic testing (such as X-rays or sputum tests), optimizing workflow and resources.
2. Turn acoustic analysis results into objective, data-based medical decision-making support data, increasing confidence in diagnosis.
3. Conduct mass screening in remote areas or high-risk communities with portable, easy-to-operate devices.
4. Position your healthcare facility as a pioneer in adopting the latest patient-centric medical technologies.

For Health Program Organizers:
1. Faster, earlier detection of TB cases means isolation and treatment can begin sooner, breaking the chain of transmission in the community.
2. The integrated dashboard provides real-time data on respiratory disease trends in a region, supporting proactive and targeted public health policies.